Adcendo

ADCendo is developing a pipeline of first- and potential best-in-class antibody-drug conjugates targeting cancers with high unmet medical needs.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2021
Adcendo Portco Hover Image